| P50 | author | Emad A. Rakha | Q55098175 |
| | Ian Ellis | Q55300055 |
| | Andrew Green | Q55098173 |
| P2093 | author name string | Dena A Jerjees | |
| | R D Macmillan | |
| | Alaa Alshareeda | |
| | M Alabdullah | |
| P2860 | cites work | Reliability and reproducibility issues in DNA microarray measurements | Q24289394 |
| | ER beta: identification and characterization of a novel human estrogen receptor | Q24317610 |
| | The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis | Q24542480 |
| | Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 |
| | Molecular portraits of human breast tumours | Q28032461 |
| | Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 |
| | Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials | Q29547513 |
| | Supervised risk predictor of breast cancer based on intrinsic subtypes | Q29617404 |
| | Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis | Q30004190 |
| | The molecular portraits of breast tumors are conserved across microarray platforms | Q33241398 |
| | Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens | Q33794421 |
| | Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer | Q34181456 |
| | Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value | Q34631710 |
| | Steroid receptors in human breast cancer | Q35879372 |
| | Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Q57130157 |
| | Proliferation marker Ki-67 in early breast cancer | Q36271525 |
| | Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer | Q36393082 |
| | Luminal B breast tumors are not HER2 positive | Q37038614 |
| | Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial. | Q37155629 |
| | Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer | Q37198196 |
| | Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. | Q38061108 |
| | High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses | Q38443265 |
| | Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer | Q39159264 |
| | Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study | Q39605778 |
| | Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers | Q40310725 |
| | The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer | Q42442027 |
| | Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes | Q42451354 |
| | Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome | Q42468745 |
| | p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas | Q42481125 |
| | Prognostic markers in triple-negative breast cancer | Q42505075 |
| | Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome | Q42516293 |
| | The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races | Q42517830 |
| | Expression of BRCA1 protein in breast cancer and its prognostic significance | Q42526565 |
| | Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes | Q43802690 |
| | Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. | Q46784173 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 317-330 | |
| P577 | publication date | 2014-04-18 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer. | |
| P478 | volume | 145 | |